Gubra Investor Relations Material
Latest events
Q2 2025
Gubra
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gubra
Access all reports
Gubra A/S is a Denmark-based biotechnology company specializing in pre-clinical contract research services and peptide-based drug discovery. The company's focus areas include metabolic and fibrotic diseases. Gubra operates through two main business segments: CRO Services and Discovery & Partnerships. It leverages advanced technology platforms and utilizes automation, robotization, digitalization, artificial intelligence, and machine learning to enhance its research capabilities. The company is headquartered in Hørsholm, Denmark, and its shares are listed on the Nasdaq Copenhagen.
Key slides for Gubra
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GUBRA
Country
🇩🇰 Denmark